EN HU

Department of Biophysics and Cell Biology

Department of Biophysics and Cell Biology
Department of Biophysics and Cell Biology
Uploaded publications:
1071
Publications in DEA:
930
OA:
297
Date range:
1965-2025
2025
1.
Nagy, L., Nagy, G., Juhász, T., Fillér, C., Szűcs, G., Szekanecz, Z., Vereb, G., Antal-Szalmás, P., Szöőr, Á.: Comparative Evaluation of Bleomycin- and Collagen-V-Induced Models of Systemic Sclerosis: insights into Fibrosis and Autoimmunity for Translational Research.
Int. J. Mol. Sci. 26 (6), 1-15, (article identifier: 2618), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
2.
Pourjamal, N., Le Joncour, V., Vereb, G., Honkamaki, C., Isola, J., Leyton, J. V., Laakkonen, P., Joensuu, H., Barok, M.: Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan.
Translational Oncology. 53, 1-9, (article identifier: 102284), 2025.
Journal metrics:
Q2 Cancer Research (2024)
Q1 Oncology (2024)
3.
Biwott, K., Singh, P., Baráth, S., Nyariki, J. N., Hevessy, Z., Bacsó, Z.: Dynamic P-glycoprotein expression in early and late memory states of human CD8+T cells and the protective role of ruxolitinib.
Biomed. Pharmacother. 182, 1-14, (article identifier: 117780), 2025.
Journal metrics:
D1 Medicine (miscellaneous) (2024)
D1 Pharmacology (2024)
4.
Ujlaky-Nagy, L., Szöllősi, J., Vereb, G.: EGFR-HER2 Transactivation Viewed in Space and Time Through the Versatile Spectacles of Imaging Cytometry - Implications for Targeted Therapy.
Cytom. Part A. [Epub ahead of print], 2025.
Journal metrics:
Q3 Cell Biology (2024)
Q1 Histology (2024)
Q1 Pathology and Forensic Medicine (2024)
5.
Bene, L., Gogolák, P., Rubovszky, B., Tóth, D., Damjanovich, L.: FRET calibration by symmetrization on the cell surface.
Opt. Laser Technol. 181, 1-14, (article identifier: 111524), 2025.
Journal metrics:
Q1 Atomic and Molecular Physics, and Optics (2024)
Q1 Electrical and Electronic Engineering (2024)
Q1 Electronic, Optical and Magnetic Materials (2024)
6.
Albar, R. A., Smith, H. L., Sanches, K., Wai, D. C. C., Naseem, M. U., Szántó, G. T., Panyi, G., Prentis, P., Norton, R. S.: Structure and functional studies of Avt1, a novel peptide from the sea anemone Aulactinia veratra.
Biochim. Biophys. Acta. Proteins Proteom. 1873 (1), 1-12, (article identifier: 141050), 2025.
Journal metrics:
Q2 Analytical Chemistry (2024)
Q2 Biochemistry (2024)
Q2 Biophysics (2024)
Q3 Molecular Biology (2024)
7.
Gergely, B., Vereb, M. A., Rebenku, I., Vereb, G., Szöőr, Á.: Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.
Cancers. 17 (5), 1-17, (article identifier: 731), 2025.
Journal metrics:
Q2 Cancer Research (2024)
Q1 Oncology (2024)
2024
8.
Tóth, A., Lente, G., Csiki, D. M., Balogh, E., Szöőr, Á., Nagy, B. J., Jeney, V.: Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification.
Front. Pharmacol. 15, 1-12, (article identifier: 1399248), 2024.
Journal metrics:
Q1 Pharmacology
Q1 Pharmacology (medical)
9.
Jusztus, V., Medyouni, G., Bagosi, A., Lampé, R., Panyi, G., Matolay, O., Maka, E., Krasznai, Z. T., Vörös, O., Hajdu, P.: Activity of Potassium Channels in CD8+ T Lymphocytes: diagnostic and Prognostic Biomarker in Ovarian Cancer?.
Int. J. Mol. Sci. 25 (4), 1-8, (article identifier: 1949), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
10.
Vishwakarma, G., Andrási, M., Szabó, R., Hajdu, P., Petrilla, V., Petrillová, M., Legath, J., Gáspár, A.: Analysis of intact venom proteins with capillary zone electrophoresis - mass spectrometry.
Microchem J. 200, 1-8, (article identifier: 110290), 2024.
Journal metrics:
Q1 Analytical Chemistry
Q1 Spectroscopy
11.
Pethő, Z., Pajtás, D., Piga, M., Magyar, Z., Zákány, F., Kovács, T., Zidar, N., Panyi, G., Varga, Z., Papp, F.: A synthetic flavonoid derivate in the plasma membrane transforms the voltage-clamp fluorometry signal of CiHv1.
FEBS J. 29 (11), 2354-2371, 2024.
Journal metrics:
D1 Biochemistry
Q1 Cell Biology
Q1 Molecular Biology
12.
Bhaumik, K. N., Spohn, R., Dunai, A., Daruka, L., Olajos, G., Zákány, F., Hetényi, A., Pál, C., Martinek, T.: Chemically diverse antimicrobial peptides induce hyperpolarization of the E. coli membrane.
Commun. Biol. 7 (1), 1-12, (article identifier: 1264), 2024.
Journal metrics:
D1 Agricultural and Biological Sciences (miscellaneous)
D1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
13.
Neefjes, J., Gurova, K., Sarthy, J., Szabó, G., Henikoff, S.: Chromatin as an old and new anticancer target.
Trends Cancer. 10 (8), 696-707, 2024.
Journal metrics:
D1 Cancer Research
D1 Oncology
14.
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: Correction: Kovács et al. ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. Pharmaceuticals 2023, 16, 488.
Pharmaceuticals. 17 (9), 1-2, (article identifier: 1137), 2024.
15.
Piga, M., Varga, Z., Fehér, Á., Papp, F., Korpos, É., Bangera, K. C., Frlan, R., Ilas, J., Dernovsek, J., Tomasic, T., Zidar, N.: Correction to "Identification of a Novel Structural Class of HV1 Inhibitors by Structure-Based Virtual Screening".
J. Chem Inf. Model. 64 (24), 9651, 2024.
16.
Ujlaky-Nagy, L., Szöllősi, J., Vereb, G.: Disrupting EGFR-HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome.
Int. J. Mol. Sci. 25 (11), 1-20, (article identifier: 5978), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
17.
Hrubi, E., Imre, L., Hegedűs, C.: Effects of EZH2 inhibitor, trichostatin A, and 5-azacytidine combinatorial treatment on osteogenic differentiation of dental pulp stem cells.
Heliyon. 10 (12), 1-7, (article identifier: 32553), 2024.
Journal metrics:
Q1 Multidisciplinary
18.
Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W. K., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D'Alessio,, F. R., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
JCI Insight. 9 (17), 1-21, (article identifier: 164009), 2024.
Journal metrics:
D1 Medicine (miscellaneous)
19.
Imre, L., Nánási, P. P. i., Benhamza, I., Enyedi, K. N., Mocsár, G., Bosire, R., Hegedűs, É., Niaki, E. F., Csóti, Á., Darula, Z., Csősz, É., Póliska, S., Scholtz, B., Mező, G., Bacsó, Z., Timmers, H. T. M., Kusakabe, M., Balázs, M., Vámosi, G., Ausio, J., Cheung, P., Tóth, K., Tremethick, D., Harata, M., Szabó, G.: Epigenetic modulation via the C-terminal tail of H2A.Z.
Nat Comms. 15 (1), 1-21, (article identifier: 9171), 2024.
Journal metrics:
D1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Chemistry (miscellaneous)
D1 Physics and Astronomy (miscellaneous)
20.
Ababneh, H. M., Tóth, A., Lente, G., Balogh, E., Csiki, D. M., Nagy, B. J., Szöőr, Á., Jeney, V.: High phosphate and calcium induce osteoblastic phenotype switching and calcification of corneal epithelial cells in a Runx2-dependent and synergistic manner; a possible mechanism of chronic kidney disease-associated corneal calcification.
Biochim. Biophys. Acta. Mol. Basis Dis. 1870 (5), 1-20, (article identifier: 167171), 2024.
Journal metrics:
Q1 Molecular Biology
Q1 Molecular Medicine
21.
Lupsa, N., Érsek, B., Böröczky, C., Kis, D., Szarka, E., Lumniczky, K., Sáfrány, G., Zádori, Z. S., Szöőr, Á., Buzás, E., Pos, Z.: High sensitivity of host Helios+/Neuropilin-1+ Treg to pretransplant conditioning hampers development of OX40 bright/integrin-β7+ regulatory cells in acute gastrointestinal GvHD.
Eur. J. Immunol. [Epub ahea dof print], 2024.
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
22.
Piga, M., Varga, Z., Fehér, Á., Papp, F., Korpos, É., Bangera, K. C., Frlan, R., Ilas, J., Dernovsek, J., Tomasic, T., Zidar, N.: Identification of a Novel Structural Class of Hv1 Inhibitors by Structure-Based Virtual Screening.
J. Chem Inf. Model. 64 (12), 4850-4862, 2024.
Journal metrics:
Q1 Chemical Engineering (miscellaneous)
Q1 Chemistry (miscellaneous)
Q1 Computer Science Applications
D1 Library and Information Sciences
23.
Medyouni, G., Vörös, O., Jusztus, V., Panyi, G., Vereb, G., Szöőr, Á., Hajdu, P.: Inhibition of K+ Channels Affects the Target Cell Killing Potential of CAR T Cells.
Cancers (Basel). 16 (22), 1-12, (article identifier: 3750), 2024.
Journal metrics:
Q2 Cancer Research
Q1 Oncology
24.
Kovács, T., Cs. Szabó, B., Kothalawala, R. C., Székelyhidi, V., Nagy, P., Varga, Z., Panyi, G., Zákány, F.: Inhibition of the HV1 voltage-gated proton channel compromises the viability of human polarized macrophages in a polarization- and ceramide-dependent manner.
Front. Immunol. 15, 1-18, (article identifier: 1487578), 2024.
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
25.
Barden, M., Elsenbroich, P. R., Haas, V., Ertelt, M., Pervan, P., Velas, L., Gergely, B., Szöőr, Á., Harrer, D. C., Bezler, V., Holzinger, A., Friis, R. U. W., Vereb, G., Schütz, G., Schoeder, C. T., Hombach, A. A., Abken, H.: Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
J. Immunother. Cancer. 12 (12), 1-14, (article identifier: 010208), 2024.
Journal metrics:
D1 Cancer Research
D1 Immunology
D1 Molecular Medicine
D1 Immunology and Allergy
D1 Pharmacology
D1 Oncology
DEENK University of Debrecen
© 2012 University of Debrecen